Data protection Impressum

Oncology

Two high-potential start-ups from Western Switzerland, HAYA Therapeutics and Neural Concept, have been named among the World Economic Forum’s 100 Technology Pioneers of 2025.

Two Lausanne-based start-ups named WEF Technology Pioneers in 2025

30 June 2025

Top Stories Western Switzerland

Top Stories from Western Switzerland (June 2025)

25 June 2025

The Lausanne University Hospital (CHUV) strengthens its oncology network with the launch of a dedicated bladder cancer center offering personalized, high-level treatment and coordinated support.

CHUV opens new bladder cancer center combining advanced care and interdisciplinary expertise

16 June 2025

Western Switzerland is rapidly becoming a hotspot for biomanufacturing and life sciences companies, thanks to its strong infrastructure, skilled talent, and business-friendly policies. Yassin Nahi, GGBa (Greater Geneva Bern area) Life Science Director, shares how the region's research hubs, academic institutions, and regulatory support make it an ideal location for companies in this sector.

Why Western Switzerland for Biomanufacturing and Life Sciences Companies: an interview with expert Yassin Nahi

Hedera Dx has secured EUR 15 million to expand hospital-based cancer diagnostics, making precision oncology more accessible to patients worldwide.

Hedera Dx raises EUR 15 million to expand access to precision cancer care

27 May 2025

Swiss Medical Network has become the first healthcare provider in Western Europe to join the prestigious Mayo Clinic Care Network. The collaboration strengthens Switzerland’s position as a hub for advanced medical innovation and international clinical partnerships.

Swiss Medical Network joins Mayo Clinic Care Network to elevate patient care

13 May 2025

HAYA Therapeutics, a precision medicine company based at Biopôle in Lausanne, has closed a USD 65 million Series A funding round to accelerate the clinical development of its RNA-guided therapies and expand its regulatory genome platform.

HAYA Therapeutics raises USD 65 million to advance RNA-guided therapies for chronic disease

12 May 2025

A collaborative research team from EPFL, the University of Geneva (UNIGE), and Geneva University Hospitals (HUG) has been awarded the 2025 Leenaards Science Prize for a pioneering project aimed at enhancing the effectiveness of immunotherapy by altering the mechanical properties of cancer cells.

Western Switzerland research teams explore new strategy to boost cancer immunotherapy

14 April 2025

Medtech start-up Novigenix has received EUR 1.8 million from the EU’s Innovative Health Initiative to support the industrialization of its AI-driven liquid biopsy platform as part of a major international cancer research collaboration.

Novigenix secures EUR 1.8 million to scale precision oncology platform

9 April 2025

TheraMe!, a Lausanne-based medtech, is transforming cancer treatment by partnering with CSEM to develop an automated, microfluidic-based instrument. This breakthrough technology enables personalized drug screening on live tumor samples, providing cancer patients with tailored therapy recommendations before treatment begins.

CSEM and TheraMe! transform cancer therapy with personalized drug screening technology

28 January 2025

1 2 3 4 5 6 … 10